| Ytd | 37.14% | |
| 1y | -54.76% |
| Open | 0.95 | Prev Close | 0.95 | Low | 0.94 | High | 0.95 | Mkt Cap | 42.00M |
| Vol | 43.00 | Avg Vol | 115.77K | EPS | -0.58 | P/E | -1.64 | Forward P/E | -3.98 |
| Beta | 0.85 | Short Ratio | 3.32 | Inst. Own | 71.62% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-14 | 50-d Avg | 1.01 | 200-d Avg | 0.94 | 1yr Est | 9.00 |
ELUT News
Gainers Advanced Biomed (NASDAQ:ADVB) shares rose 24.1% to $6.24 during Monday's pre-market ses
Elutia (NASDAQ:ELUT) sells SimpliDerm to Cellution Biologics for up to $11M to boost its balance she
Elutia Signs Definitive Agreement to Sell SimpliDerm® in Transaction Valued at up to $11 Million, St
GAITHERSBURG, Md., June 11, 2026 (GLOBE NEWSWIRE) -- Elutia Inc. (Nasdaq: ELUT) ("Elutia" or the "Co
GAITHERSBURG, Md., May 18, 2026 (GLOBE NEWSWIRE) -- Elutia Inc. (Nasdaq: ELUT) ("Elutia" or the "Com
Elutia Inc. (ELUT) Q1 2026 Earnings Call Transcript
NXT-41 review advancing collaboratively with FDA, informing NXT-41x submission preparations Brought
Gaithersburg, Maryland--(Newsfile Corp. - May 14, 2026) - Elutia Inc. (NASDAQ: ELUT) ("Elutia" or th
GAITHERSBURG, Md., May 14, 2026 (GLOBE NEWSWIRE) -- Elutia Inc. (Nasdaq: ELUT) (“Elutia” or the “Com
GAITHERSBURG, Md., April 30, 2026 (GLOBE NEWSWIRE) -- Elutia Inc. (Nasdaq: ELUT) (“Elutia” or the “C
GAITHERSBURG, Md., March 17, 2026 (GLOBE NEWSWIRE) -- Elutia Inc. (Nasdaq: ELUT) (“Elutia” or the “C
GAITHERSBURG, Md., March 13, 2026 (GLOBE NEWSWIRE) -- Elutia Inc. (Nasdaq: ELUT) ("Elutia" or the "C
Elutia Inc. (ELUT) Q4 2025 Earnings Call Transcript
– Base biologic matrix NXT-41 submitted to FDA; on track for anticipated FDA clearance in second hal
GAITHERSBURG, Md., March 04, 2026 (GLOBE NEWSWIRE) -- Elutia Inc. (Nasdaq: ELUT) ("Elutia" or the "C
GAITHERSBURG, Md., March 02, 2026 (GLOBE NEWSWIRE) -- Elutia Inc. (Nasdaq: ELUT) ("Elutia" or the "C
GAITHERSBURG, Md., Feb. 25, 2026 (GLOBE NEWSWIRE) -- Elutia Inc. (Nasdaq: ELUT) (“Elutia” or the “Co
GAITHERSBURG, Md., Feb. 18, 2026 (GLOBE NEWSWIRE) -- Elutia Inc. (Nasdaq: ELUT) (“Elutia” or the “Co
Fourth quarter revenue up 16% year-over-year, $26.9M of secured debt eliminated, and total cash and
Elutia Inc. (NASDAQ: ELUT - Get Free Report)'s stock price shot up 4.7% on Friday. The company trade
Company to present Tuesday, January 13 th at 10:00 a.m. PT / 1:00 p.m.
ELUTIA INC (ELUT) might move higher on growing optimism about its earnings prospects, which is refle
